Azione 300119 TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Tianjin Ringpu Bio-Technology Co.,Ltd.

Azioni

300119

CNE100000TV1

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 18/04/2024 		Variaz. 5gg Var. 1 gen.
15,76 CNY -1,01% Grafico intraday di Tianjin Ringpu Bio-Technology Co.,Ltd. +0,51% -3,84%
29/03 Tianjin Ringpu Bio-Technology Co.,Ltd. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023 CI
2023 Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) annuncia un riacquisto di azioni per un valore di 80 milioni di CNY. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on October 27, 2023, has closed with 3,689,608 shares, representing 0.8% for CNY 59.99 million.
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.
Tianjin Ringpu Bio-Technology Co.,Ltd. authorizes a Buyback Plan.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for 2022
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022
Tianjin Ringpu Bio-Technology Co.,Ltd. signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Executive Appointments
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 300119
  4. Notizie Tianjin Ringpu Bio-Technology Co.,Ltd.
  5. Altre lingue